Postgraduate medical education for the SGLT2-GLP-1-HRT-CGRP era
Three FHEQ Level 7 Postgraduate Certificates for UK GPs, prescribing pharmacists, and advanced clinical practitioners — in Diabetes-Cardiorenal-Metabolic Medicine, Menopause and Andropause, and Clinical Headache Management. 60 UK credits, 30 ECTS, awarded by New Vision University UK Campus.
Last editorial review: 14 May 2026 · Next scheduled refresh: 1 December 2026.
Three routes through MD Acumen
The platform serves individual clinicians seeking extended-scope competence, NHS commissioners closing capability gaps in their workforce, and university partners seeking ready-to-deliver postgraduate qualifications.
Individual professional development
UK GPs, prescribing pharmacists, advanced clinical practitioners and nurse independent prescribers seeking FHEQ Level 7 credentials in diabetes-cardiorenal-metabolic medicine, menopause and andropause, or clinical headache management.
ICBs & NHS Training Hubs
Integrated Care Boards commissioning extended-scope workforce capability for neighbourhood-level multimorbid care. Cohort-of-thirty PGCert delivery, Capstone audits aligned to local ICB priorities, six-block academic quality-assurance.
International medical school partners
European, Middle Eastern, and Asian medical schools seeking ready-to-deliver FHEQ Level 7 postgraduate programmes with ECTS conformance, NVU UK Campus awarding, and a defensible academic governance dossier.
Three PGCert programmes, one architecture
Each programme is structured as four 15-credit microcredentials at FHEQ Level 7, delivered part-time over 30 weeks with weekly synchronous lectures, SCORM lessons, end-of-week Synoptics, and a Capstone in one of five formats.
DCRM
Diabetes-Cardiorenal-Metabolic Medicine
The interface of type 2 diabetes, chronic kidney disease, heart failure, atherosclerotic cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease — anchored to NICE NG28, KDIGO 2024, the ESC/EAS 2025 dyslipidaemia focused update, and the DCRM 2.0 framework.
Menopause & Andropause
Hormonal transitions, female and male
Perimenopausal physiology, MHT prescribing, the cardiometabolic-bone-cognitive interface, andropause and male hormonal health — anchored to NICE NG23 (Nov 2024), the BMS HRT Guide, NICE TA1143 (fezolinetant), and the BSSM 2022 testosterone-deficiency framework.
Clinical Headache Management
Migraine, the TACs, and secondary headache
Migraine, the trigeminal autonomic cephalalgias, medication-overuse headache, and red-flag secondary pathways — anchored to NICE CG150, ICHD-3, the IHS 2025 evidence-based guidelines, and the full UK CGRP-era armamentarium (gepants TA871/TA919/TA973, mAbs TA682/TA631/TA659/TA764).
From free Mini-module to full PGCert
Enter at any tier and progress as far as your clinical role requires. The three tiers are credentialled separately, so progression is optional and recognised at every stage.
Strategic resources
Two open-access reference documents for ICB Training Hub leads, NVU academic governance, and university partnership officers.
Capability Statement
Single-document brief on MD Acumen as a programme delivery partner — architecture, governance, fee structure, partnership models, and the six-block academic quality-assurance scheme.
Pivotal Guideline Bundle 2024–2026
Eight UK and international guideline shifts that change primary-care prescribing, mapped to the credentialled MD Acumen curriculum. Updated quarterly at the 1 December refresh cadence.
Two ways to begin
No application form, no commitment. Each route is designed to demonstrate the rigour of the platform before any enrolment decision.
Free Mini-module
A four-hour postgraduate-level taster of each PGCert. Includes an aligned synoptic self-assessment and a Certificate of Professional Learning Activity.
Primary Care Masterclass
Two-hour virtual masterclasses tied to the latest guideline shifts. Recorded, transcribed, and converted into a digest within 48 hours.
Awarded by, delivered by, and curriculum-aligned with.
The microcredentials and the full PGCert qualifications are awarded by New Vision University (Tbilisi, Georgia) — UK Campus. Programme design and delivery is by MD Acumen Ltd as the operating partner.
Curriculum is mapped to, and formal partnership-development conversations are open with: NHS England; the Royal College of General Practitioners (RCGP); the Federation of the Royal Colleges of Physicians of the UK; the Royal College of Obstetricians and Gynaecologists (RCOG); the British Menopause Society (BMS); the Faculty of Sexual and Reproductive Healthcare (FSRH); the British Society for Sexual Medicine (BSSM); the British Association for the Study of Headache (BASH); the Primary Care Cardiovascular Society (PCCS); the Primary Care Diabetes Society (PCDS); the Society for Endocrinology; and local ICB Training Hubs. ECTS conformance is via NVU's institutional accreditation within the European Higher Education Area, mapped to FHEQ Level 7 / EQF Level 7.
Note. "Curriculum-aligned with" describes explicit content mapping to a body's published guidelines. Formal endorsement letters will be sought during the NVU academic-approval phase. This page never claims endorsement that has not been confirmed in writing.
Educational disclaimer. Intended for the continuing professional development of qualified UK healthcare professionals. Does not replace clinical judgement, local prescribing formularies, or specialist advice. Drug doses and recommendations reflect UK practice at the time of authoring; readers must check the current British National Formulary and the relevant NICE guidance before prescribing.
© 2026 MD Acumen Ltd · Registered in England and Wales · 16538952 · Legal & Regulatory Information · enquiry@mdacumen.com